A5092348315- Congenital Heart Disease Studies
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Cardiac tumors and thrombi
- Cardiac Structural Anomalies and Repair
- Coronary Artery Anomalies
- Cardiovascular Disease and Adiposity
- Vascular anomalies and interventions
- Cardiomyopathy and Myosin Studies
- Eosinophilic Disorders and Syndromes
- Heart Rate Variability and Autonomic Control
- Hepatocellular Carcinoma Treatment and Prognosis
- Systemic Sclerosis and Related Diseases
- Cancer Treatment and Pharmacology
- Cardiovascular and Diving-Related Complications
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Histiocytic Disorders and Treatments
- Electron Spin Resonance Studies
- Renal cell carcinoma treatment
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Body Contouring and Surgery
- Cardiac Valve Diseases and Treatments
- Atherosclerosis and Cardiovascular Diseases
- Congenital heart defects research
Instituto Nacional de Cardiología
2024-2025
Universidad La Salle
2024
Mexfam
2023
Adipose tissue distribution plays a crucial role in the development of cardiovascular complications. In particular, visceral adipose (VAT) has been linked to insulin resistance (IR) and disease (CVD). However, relationship between VAT, cardiac dysfunction meditation capacity VAT related IR not fully characterized. This cross-sectional study included adults living with type 2 diabetes (T2D). was measured using electrical bioimpedance also estimated Metabolic Score for Visceral Fat (METS-VF)....
Abstract Background Cardiotoxicity is a recognized complication in breast cancer (BC) patients undergoing chemotherapy with anthracyclines or without trastuzumab. However, the prognostic value of heart rate variability (HRV) indexes for early cardiotoxicity development remains unknown. Methods Fifty BC underwent TTE assessment before and three months after chemotherapy. HRV were obtained from continuous electrocardiograms supine position spontaneous breathing, active standing, controlled...
A 54-year-old woman with a diagnosis of Erdheim-Chester disease under therapy dabrafenib presents clinical signs heart failure. After discontinuing the offending medication and initiating guideline-directed medical for failure reduced ejection fraction, picture improved.
Abstract Background The increasing prevalence of cancer therapy-related cardiovascular toxicity (CTRCD) poses a significant challenge to patient management, necessitating accurate risk assessments. Previous methodologies have struggled with precise stratification, partly due varying definitions CTRCD and the specificity treatments. Purpose This study aimed evaluate assessment tool proposed by Heart Failure Association International Cardio-Oncology Society (HFA-ICOS) in predicting patients...
Abstract Background Anthracyclines and trastuzumab continue to be within the most popular systemic agents used in breast cancer treatment. Nonetheless, their cardiotoxic effects contribute significant morbidity mortality, which have been extensively studied acknowledged. Left ventricular impairment remodeling due chemo- target-therapy induced cardiotoxicity has well described. However, on right function not fully elucidated are incompletely understood. Purpose We aim comprehensively assess...
Abstract Background Cardiotoxicity is a recognized complication in breast cancer (BC) patients undergoing chemotherapy with anthracyclines or without trastuzumab. However, the prognostic value of heart rate variability (HRV) indexes for early cardiotoxicity development remains unknown. Purpose This study aimed to investigate cardiac autonomic responses physiological stimuli BC treated trastuzumab, and evaluate predictive transthoracic echocardiography (TTE) findings HRV cardiotoxicity....
Abstract Introduction Ectopic deposition of adipose tissue, particularly visceral tissue (VAT) has been identified as a significant contributor to cardiometabolic complications among individuals with type 2 diabetes (T2D). An increase in VAT suggested cause cardiac dysfunction, which may lead echocardiographic abnormalities such alterations speckle-tracking and left ventricular ejection fraction (LVEF). However, this relationship not fully elucidated. Purpose This study aims determine the...
Abstract Background Pulmonary tumour embolism is a rare entity that can arise from wide variety of neoplasms. It initially manifest as pulmonary with right heart failure and be refractory to thrombolytic therapy. Cholangiocarcinoma malignancy arises the epithelium biliary tree, representing 3% all gastrointestinal malignancies, being intrahepatic cholangiocarcinoma second most common liver after hepatocellular carcinoma. Case summary This case regards patient presented our centre acute...
Mid-ventricular hypertrophic cardiomyopathy is a rare subgroup within cardiomyopathies that may present with apical aneurysm. This condition associated an increased risk of cardiac adverse events, including arrest, heart failure, thromboembolic or sudden death. We case 41-year-old man who presented history exertional dyspnea and syncope. Multimodality imaging echocardiography magnetic resonance showed hypertrophy the mid-ventricular segments An implantable cardioverter-defibrillator was...